Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome.
Keratoprosthesis was implanted in 17 eyes with ocular pemphigoid and 7 eyes with Stevens-Johnson syndrome and followed for 6 months to 6 years. Visual outcomes and complications were compared. Pemphigoid was found to have a much better prognosis than did Stevens-Johnson syndrome. Keratoprosthesis is now firmly indicated in elderly pemphigoid patients whose vision in both eyes has become reduced to hand movements or less due to a corneal opacity.
Dohlman
C H
CH
Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Terada
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001705:Bioprosthesis; D003228:Conjunctiva / Q000601:surgery*; D015352:Dry Eye Syndromes / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D020366:Methylmethacrylate; D008768:Methylmethacrylates; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000150:complications*; D011379:Prognosis; D013262:Stevens-Johnson Syndrome / Q000601:surgery*; D013997:Time Factors; D014792:Visual Acuity
D008768:Methylmethacrylates; D020366:Methylmethacrylate